RetinalGenix Technologies (RTGN) Other Non-Current Liabilities (2022 - 2026)

RetinalGenix Technologies has disclosed Other Non-Current Liabilities across 5 years of filings, most recently posting $831000.0 for Q1 2026.

• Other Non-Current Liabilities for Q1 2026 came in at $831000.0, up 63.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $831000.0 (up 63.99% YoY), and the FY2025 annual result was $489224.0, up 4.58% from the prior year.
• Other Non-Current Liabilities came in at $831000.0 for Q1 2026 at RetinalGenix Technologies, up from $489224.0 in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $831000.0 in Q1 2026 to a low of $900.0 in Q3 2023.
• The 5-year median for Other Non-Current Liabilities is $467793.0 (2024), against an average of $387547.0.
• Across the five-year window, Other Non-Current Liabilities retreated 2.5% in 2023 and jumped 56455.56% in 2024, its largest moves.
• RetinalGenix Technologies' Other Non-Current Liabilities stood at $109185.0 in 2022, then surged by 319.04% to $457534.0 in 2023, then grew by 2.24% to $467793.0 in 2024, then climbed by 4.58% to $489224.0 in 2025, then jumped by 69.86% to $831000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $831000.0 (Q1 2026), $489224.0 (Q4 2025), and $539000.0 (Q3 2025), per Business Quant data.